WALLIS MOLCHEN to Carcinoma, Hepatocellular
This is a "connection" page, showing publications WALLIS MOLCHEN has written about Carcinoma, Hepatocellular.
Connection Strength
0.009
-
Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Trials. 2009 Dec; 6(6):618-27.
Score: 0.009